Premium
The effect of high‐dose methotrexate on renal tubules as indicated by urinary lysozyme concentration
Author(s) -
FreemanNarrod Marian,
Kim Jung S.,
Ohanissian Hanrik,
Mills Keith,
Smiley Joseph W.,
Djerassi Issac
Publication year - 1982
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19821215)50:12<2775::aid-cncr2820501214>3.0.co;2-e
Subject(s) - lysozyme , medicine , urinary system , methotrexate , urology , biochemistry , biology
Lysozyme was measured after 186 doses of methotrexate (MTX) to 88 patients. After 7.5% of the doses, lysozyme rose to between 2 and 19 m̈g/cc and in 3.2% it rose to between 20 and 120 m̈g/cc. These increases had no relationship to the age of the patients, their dose of MTX, the total number of times that MTX had been given, nor to rises in serum creatinine. It did correlate with the administration of aminoglycosides (a part of the supportive care of these patients) in two thirds of these cases. In the patients who did not receive aminoglycosides, no urinary lysozyme concentration rose above 19 m̈g/cc, not even in the patients who became oliguric or required hemoperfusion. Most of these rises occurred early and were of 24 to 48 hour duration. The rises occurring after five days were persistent and were associated with prolonged MTX serum concentrations, suggesting that tubular damage due to MTX was the result of prolonged exposure to MTX, rather than the primary cause of kidney damage, i.e. , the event causing the prolonged serum concentrations.